Sangamo Therapeutics | DEF 14A: Definitive information statements
Apr 20 04:06
Sangamo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 4 05:21
Sangamo Therapeutics | 8-K: Current report
Mar 26 05:09
Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Mar 13 19:58
Sangamo Therapeutics | 8-K: Current report
Feb 7 05:39
Sangamo Therapeutics | 8-K: Current report
Jan 19 13:00
Sangamo Therapeutics | 8-K: Current report
Dec 13, 2023 20:55
Sangamo Therapeutics | 8-K: Current report
Nov 4, 2023 04:02
Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
Nov 2, 2023 04:02
Sangamo Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 9, 2023 04:47
Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2023 FINANCIAL RESULTS
Aug 9, 2023 04:08
Sangamo Therapeutics | 8-K: Current report
Jun 3, 2023 04:58
Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS PRELIMINARY FIRST QUARTER 2023 FINANCIAL RESULTS
Apr 27, 2023 05:22
Sangamo Therapeutics | DEF 14A: Definitive proxy statements
Apr 17, 2023 18:03
Sangamo Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Apr 6, 2023 04:01
Sangamo Therapeutics | 8-K: Current report
Mar 18, 2023 05:14
Sangamo Therapeutics | 8-K: Current report
Mar 14, 2023 21:43
Sangamo Therapeutics | 8-K: Current report
Mar 11, 2023 06:17
Sangamo Therapeutics | 8-K: Current report
Mar 7, 2023 19:49
Sangamo Therapeutics | 8-K: Current report
Mar 3, 2023 06:05
No Data
No Data